Furthermore, the proliferative and invasive effects of ERβ have been demonstrated in BCa cell lines (UMUC3 and J82), where ERβ signaling also enhances cisplatin resistance by increasing β-catenin activity and promoting tumor growth [38,89,90]. This evidence concerns the gene ESR2 and neoplasm.